Search

Your search keyword '"Berg‐Hansen, Pål"' showing total 182 results

Search Constraints

Start Over You searched for: Author "Berg‐Hansen, Pål" Remove constraint Author: "Berg‐Hansen, Pål"
182 results on '"Berg‐Hansen, Pål"'

Search Results

4. Restriction spectrum imaging of white matter and its relation to neurological disability in multiple sclerosis

5. Peripapillary retinal layer thickness is associated with retinal oxygen saturation in newly diagnosed patients with multiple sclerosis

11. Oligoclonal band phenotypes in MS differ in their HLA class II association, while specific KIR ligands at HLA class I show association to MS in general

12. Information from ecological momentary assessments lead to over-medicalization: Yes.

14. Serum neurofilament light chain concentration predicts disease worsening in multiple sclerosis

15. Exploring Retinal Blood Vessel Diameters as Biomarkers in Multiple Sclerosis

17. sj-pdf-2-msj-10.1177_13524585221097296 – Supplemental material for Serum neurofilament light chain concentration predicts disease worsening in multiple sclerosis

18. sj-docx-13-msj-10.1177_13524585221097296 – Supplemental material for Serum neurofilament light chain concentration predicts disease worsening in multiple sclerosis

19. sj-docx-9-msj-10.1177_13524585221097296 – Supplemental material for Serum neurofilament light chain concentration predicts disease worsening in multiple sclerosis

20. sj-docx-8-msj-10.1177_13524585221097296 – Supplemental material for Serum neurofilament light chain concentration predicts disease worsening in multiple sclerosis

21. sj-pdf-3-msj-10.1177_13524585221097296 – Supplemental material for Serum neurofilament light chain concentration predicts disease worsening in multiple sclerosis

22. sj-pdf-1-msj-10.1177_13524585221097296 – Supplemental material for Serum neurofilament light chain concentration predicts disease worsening in multiple sclerosis

23. sj-pdf-4-msj-10.1177_13524585221097296 – Supplemental material for Serum neurofilament light chain concentration predicts disease worsening in multiple sclerosis

25. A Comparison of Brain Age Estimation And Brain Parenchymal Fraction as Imaging Markers in Multiple Sclerosis

29. Genetic variants are major determinants of CSF antibody levels in multiple sclerosis

31. sj-pdf-4-mso-10.1177_2055217321999826 - Supplemental material for High prevalence of fatigue in contemporary patients with multiple sclerosis

39. Retinal oximetry as a biomarker in multiple sclerosis

40. Supplemental Material6 - Supplemental material for No differential gene expression for CD4+ T cells of MS patients and healthy controls

41. No differential gene expression for CD4+ T cells of MS patients and healthy controls

42. MSJ765671_supplementary_material_4 – Supplemental material for Restriction spectrum imaging of white matter and its relation to neurological disability in multiple sclerosis

43. Increased DNA methylation of SLFN12 in CD4+ and CD8+ T cells from multiple sclerosis patients

45. Restriction spectrum imaging of white matter and its relation to neurological disability in multiple sclerosis

47. No differential gene expression for CD4+ T cells of MS patients and healthy controls.

48. Increased DNA methylation of SLFN12 in CD4+ and CD8+ T cells from multiple sclerosis patients.

49. Environmental exposures and the risk of multiple sclerosis investigated in a Norwegian case-control study

Catalog

Books, media, physical & digital resources